(Date:11/20/2009)...O recently announced that Dr. Dominique Hebrault w...cess Analytical Technology (PAT) in Green Chemistr.... , (PRWEB) November 20, ... Technology (PAT) in Green Chemistry and Green Eng...l Technology (PAT) case studies will be presented ...
(Date:11/19/2009)...-FirstCall/ -- Omeros Corporation (Nasdaq: OMER )...he third quarter ended September 30, 2009. For the...orted a net loss of $3.9 million, or $1.34 per sha...$2.54 per share, for the same period in 2008. For ...any reported a net loss of $15.5 million, or $5.29...
(Date:11/19/2009)...e-FirstCall/ -- NeoStem, Inc. (NYSE Amex: NBS ), ...ter to its shareholders, discussing the Company,s ...maceuticals Holdings, Inc. (CHBP), an integrated b...public of China. The merger gives NeoStem a contro...o. Ltd., CHBP,s primary operating subsidiary and a...
(Date:11/19/2009)...ember 19 MONITORING FORCE GmbH,ann... Flibanserin in the,indication treatment-relevant ... for orphan drug status designation with the Europ...inesia is a complication of the mainstay,treatment...ome of those,affected, since it may be disabling f...
Breaking Biology Technology:Process Analytical Technology (PAT) in Green Chemistry and Green Engineering 2Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 2Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 3Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 4Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 5Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 6Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 7Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 8NeoStem Outlines to Shareholders Near-term and Long-term Business Strategies Following Acquisition of Chinese Pharmaceutical Company 2NeoStem Outlines to Shareholders Near-term and Long-term Business Strategies Following Acquisition of Chinese Pharmaceutical Company 3MONITORING FORCE GmbH Requests Acknowledgment of Flibanserin as "Orphan Drug" 2...search and development funding has exceeded expect...o a new report. The state had set a target of $3.3... th nationally in private R&D spending per capita...be hard-pressed to find an industry to match the g...Ward, president of NorthStar Economics , an econ...
...ts at Chippewa Valley Technical College in Eau Cla...icro-level surface analysis to firms or organizati...ojects. , ,Instructor Hans Mikelson says three stu...t completion by December 15, 2005. Mikelson belie...tron microscope are the best likely partners. A m...
...Facilities, Inc. , a global leader in the design, ...on networks, technology networks and security syst...provide network design and deployment services for...al Wi-Fi network. Working together with communicat...n with Madison Gas & Electric, WFI will deploy a W...
Other Biology Technology:New report says Wisconsin R&D spending exceeding expectations 2...nly collapse, it can be due to hereditary cardiac ...Hospital have now discovered a genetic modificatio...l. Just one "false" amino acid can give zebrafish ...akeup similar to that of humans, these defects cou...sufficiency is not just a disease that results fro...
... for rejoicing, many people who have undergone the...disease unfortunately suffer from a physical and m...ely dysfunctional symptom ranges from fatigue and ...possible brain damage. In CHEMOBRAIN: HOW CANCER ... $18.98), a clear, concise guide for cancer patien...
...affected with retinitis pigmentosa (RP), a disease...s to blindness. Now, a University of Missouri rese...and humans for two different forms of RP. This dis...rapies that will benefit both cats and humans. , ... blindness in humans also cause retinal blindness ...
Other Biology News:Why 'lazy Susan' has a weak heart 2ChemoBrain: How cancer therapies can affect your mind 2Cats' eye diseases genetically linked to diseases in humans 2QCapture PRO from QImaging
Mouse Anti-Ia Antigen Monoclonal Antibody, Biotin Conjugated, Clone CIa from Abcam
Rabbit Anti-Dardarin Antibody, Unconjugated from CHEMICON
Mouse Anti-Mannose Receptor Monoclonal Antibody, Biotin Conjugated, Clone 15-Feb from Abcam
Biology Products: